You are here: Industry Insights > Market News > South Africa asks SII to take back one million doses of COVID-19 vaccine: Reports

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate

Neohesperidin

Advantame

Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench

Pharma and Food Grade, USP/FCC Neotame Sweetener E961

Trilobatin

South Africa asks SII to take back one million doses of COVID-19 vaccine: Reports

expresspharmaFebruary 18, 2021

Tag: South Africa , COVID-19 vaccine , 501Y.V2 , SII

Favorites

South Africa has asked the Serum Institute of India to take back one million doses of COVID-19 vaccine that the company had sent in early February, as per a report in The Economic Times.

The company did not immediately respond to a Reuters request for comment.

South Africa’s health minister had informed last week that the government could sell AstraZeneca’s vaccine after the country halted its rollout following a small clinical trial that showed it offered minimal protection against mild to moderate illness from the 501Y.V2 coronavirus variant.

Previous:Glenmark launches SUTIB (Sunitinib) capsules in India to treat kidney cancer

Next:Research reveals Pfizer-BioNTech COVID-19 vaccine elicits strong immune response with single dose

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

South Africa asks SII to take back one million doses of COVID-19 vaccine: Reports | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

South Africa asks SII to take back one million doses of COVID-19 vaccine: Reports

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may like
More>>

South Africa asks SII to take back one million doses of COVID-19 vaccine: Reports

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may likeMore>>

You may like
More>>